Cerus to Release Third Quarter 2017 Results on November 2, 2017
19 October 2017 - 11:30PM
Business Wire
Cerus Corporation (NASDAQ:CERS) announced today that its third
quarter results will be released on Thursday, November 2, 2017,
after the close of the stock market. The company will host a
conference call and webcast at 4:15 PM ET that afternoon, during
which management will discuss the company’s financial results and
provide a general business overview and outlook.
To access the live webcast, please visit the Investor Relations
page of the company’s website at http://www.cerus.com/ir.
Alternatively, you may access the live conference call by dialing
866-235-9006 (U.S.) or 631-291-4549 (international).
A replay will be available on the company’s website, or by
dialing (855) 859-2056 (U.S.) or (404) 537-3406 (international) and
entering conference ID number 82994688. The replay will be
available approximately three hours after the call through November
16, 2017.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused in
the field of blood transfusion safety. The INTERCEPT Blood System
is designed to reduce the risk of transfusion-transmitted
infections by inactivating a broad range of pathogens such as
viruses, bacteria and parasites that may be present in donated
blood. The nucleic acid targeting mechanism of action of the
INTERCEPT treatment is designed to inactivate established
transfusion threats, such as hepatitis B and C, HIV, West Nile
virus and bacteria, as well as emerging pathogens such as
Chikungunya, malaria and dengue. Cerus currently markets and sells
the INTERCEPT Blood System for both platelets and plasma in the
United States, Europe, the Commonwealth of Independent States, the
Middle East and selected countries in other regions around the
world. The INTERCEPT red blood cell system is in clinical
development. See http://www.cerus.com for information about
Cerus.
INTERCEPT and INTERCEPT Blood System are trademarks of Cerus
Corporation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171019005540/en/
Cerus CorporationTim Lee, 925-288-6137Investor Relations
Directorir@cerus.com
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Apr 2024 to May 2024
Cerus (NASDAQ:CERS)
Historical Stock Chart
From May 2023 to May 2024